Healthcare Analytical Testing Services Market

Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025

Report Code: AST 4341 Apr, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Healthcare Analytical Testing Services Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Healthcare Analytical Testing Services Market

Request For Special Pricing

[327 Pages Report] The global healthcare analytical testing services market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4%. In the current global scenario-where the focus on biologics and biosimilars has risen-it is expected that the benefits of advanced healthcare analytical testing services will ensure their greater adoption. The increasing demand for specialized testing services, the number of clinical trials, and the acceptance of the QbD approach in pharmaceutical research and manufacturing are other factors driving the growth of this market.

Healthcare Analytical Testing Services Market

The batch-release testing segment is projected to grow at the highest CAGR during the forecast period

Within the type segment, the market is segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing services, microbial testing services, and environmental monitoring services. The batch-release testing segment is projected to grow at the highest CAGR during the forecast period. Within the batch-release testing services segment, the dissolution testing services market is projected to grow at the highest growth rate during the forecast period.

Pharmaceutical & biopharmaceutical companies hold the largest share in the market

Based on the end user, the market is broadly classified into pharmaceutical & biopharmaceutical companies, medical device companies, and contract research organizations (CROs). Pharmaceutical & biopharmaceutical companies hold the largest share in the market. The largest share of this segment in the market can be attributed to the tremendous amount of analytical testing required to support a product from discovery, development, and clinical trials, through manufacturing and marketing.

Healthcare Analytical Testing Services Market

North America holds the largest share in the healthcare analytical testing services market, by region

North America held the largest share in the healthcare analytical testing services market in 2019. This dominance of North America in this market is due to the presence of many pharmaceutical and biopharmaceutical companies, high investments and rising focus on the biosimilars & biologics segment, and high allocation to R&D. The Asia Pacific market is expected to register the highest growth during the forecast period, primarily due to the lower production costs and growing favorability of the regulatory environment.

Key market players

The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), LabCorp (US), SGS (Switzerland), Charles River Laboratories (US), WuXi PharmaTech (China), PPD (US), Element Materials Technology (UK), Pace Analytical (US), Intertek (UK), Merck KGAA (Germany), Source BioScience (UK), Almac Group (Ireland), ICON (Ireland), Frontage Labs (US), STERIS PLC (US), PRA Health Sciences (US), Syneos Health (US), Medpace Holdings (US), LGC Limited (UK), and Anacura (Belgium).

Scope of the Report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

  • Type, end user, and region

 

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa

The research report categorizes the market into the following segments and subsegments:

By Type

  • Bioanalytical Testing Services
    • Cell-based Assays
    • Virology Testing
    • Immunogenicity & Neutralizing Antibody Testing
    • Biomarker Testing
    • Pharmacokinetic Testing
    • Other Bioanalytical Testing Services
  • Physical Characterization Services
    • Laser Particle Size Analysis
    • Thermal Analysis
    • Image Analysis
    • Surface Area Analysis
    • Other Physical Characterization Services
  • Method Development & Validation Services
    • Extractable & Leachable Method Development & Validation;
    • Process Impurity Method Development & Validation;
    • Stability-indicating Method Validation
    • Cleaning Validation
    • Analytical Standard Characterization
    • Technical Consulting
    • Other Method Development & Validation Services
  • Raw Material Testing Services
    • Complete Compendial Testing
    • Heavy Metal Testing
    • Container Testing
    • Karl Fischer Analysis
    • Wet Chemistry Analysis
    • Other Raw Material Testing Services
  • Batch-release Testing Services
    • Dissolution Testing
    • Elemental Impurity Testing
    • Disintegration Testing
    • Hardness Testing
    • Friability Testing
    • Other Batch-release Testing Services
  • Stability Testing
    • Drug Substance Stability Testing
    • Formulation Evaluation Stability Testing
    • Accelerated Stability Testing
    • Photostability Testing
    • Comparative Stability Testing
    • Other Stability Testing Services
  • Microbial Testing Services
    • Microbial Limit Testing
    • Sterility Testing
    • Endotoxin Testing
    • Preservative Efficacy Testing
    • Water Testing
    • Other Microbial Testing Services
  • Environmental Monitoring Services
    • Air Testing
    • Wastewater/ETP Testing
    • Other Environmental Monitoring Services

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Contract Research Organizations

By Country/Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Switzerland
    • Spain
    • Rest of Europe (RoE);
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of APAC
  • Latin America
  • Middle East and Africa

Recent Developments

  • In January 2020, LabCorp’s Drug Development Business launched Preclinical, Clinical, and Post-Approval Cell, and Gene Therapy Development Solutions
  • In June 2019, Eurofins Scientific acquired Transplant Genomics Inc. (US) to expand its transplantation testing footprint
  • In May 2019, SGS acquired Chemical Solutions Ltd. (CSL) (US), a testing laboratory specializing in elemental and heavy metal testing for food, nutraceuticals, pharma, and cosmetic products
  • In December 2019, Frontage Labs partnered with J&J Corporate Services, Inc. (US) to expand its foothold in Canada and the west coast of North America.
  • In March 2018, Charles River Laboratories added 2,800-ft2 of cleanrooms dedicated to GMP microbial and mammalian cell banking at its site in Malvern, Pennsylvania.

Critical questions the report answers:

  • Where will all these acquisitions, partnerships, agreements, and expansions take the healthcare analytical testing services industry in the mid-to-long term?
  • What are the healthcare analytical testing services that hold the highest share in the market?
  • Which segments in the healthcare analytical testing services market are likely to witness growth in the forecast period?
  • Which end users will benefit the most from the growth in the healthcare analytical testing services market?
  • Which geographies are likely to grow at the highest CAGR?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary sources
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 42)

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
    4.2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: REGIONAL MIX (2020–2025)
    4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Focus on analytical testing of biologics & biosimilars
                    5.2.1.2 Increasing outsourcing of analytical testing by pharmaceutical companies
                    5.2.1.3 Increasing number of clinical trials
                    5.2.1.4 Rising acceptance of the Quality-by-Design approach in pharma research and manufacturing
           5.2.2 RESTRAINTS
                    5.2.2.1 Shortage of skilled professionals
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Specialized testing
                    5.2.3.2 Emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Specific requirements of innovative formulations and medical devices
                    5.2.4.2 Need to improve the sensitivity of bioanalytical methods

6 INDUSTRY INSIGHTS (Page No. - 57)
    6.1 INDUSTRY TRENDS
           6.1.1 FOCUS ON ACQUISITIONS TO ENHANCE CAPABILITIES AND SERVICE PORTFOLIO
           6.1.2 LONG-TERM OUTSOURCING AND PREFERRED VENDOR PARTNERSHIPS
    6.2 REGULATORY ANALYSIS
    6.3 IMPACT OF COVID-19 ON HEALTHCARE ANALYTICAL TESTING SERVICES

7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE (Page No. - 64)
    7.1 INTRODUCTION
    7.2 BIOANALYTICAL TESTING SERVICES
           7.2.1 CELL-BASED ASSAYS
                    7.2.1.1 Cell-based assays help check the strength and stability of the product through all phases of clinical study
           7.2.2 VIROLOGY TESTING
                    7.2.2.1 Potential effects of viral contamination support demand for testing services
           7.2.3 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING
                    7.2.3.1 Increasing application of immunogenicity & neutralizing antibodies to drive the market during forecast period
           7.2.4 BIOMARKER TESTING
                    7.2.4.1 Emphasis on development of personalized medicines to drive biomarker testing services market
           7.2.5 PHARMACOKINETIC TESTING
                    7.2.5.1 Increasing incidence of infectious diseases will augment market growth
           7.2.6 OTHER BIOANALYTICAL TESTING SERVICES
    7.3 PHYSICAL CHARACTERIZATION SERVICES
           7.3.1 LASER PARTICLE SIZE ANALYSIS
                    7.3.1.1 Need to maintain particle size uniformity and consistency in pharmaceutical drug products is driving market growth
           7.3.2 THERMAL ANALYSIS
                    7.3.2.1 Rising use of analyzers in research to further support the growth of the market
           7.3.3 IMAGE ANALYSIS
                    7.3.3.1 Need to identify product structures during drug development has sustained demand for image analysis
           7.3.4 SURFACE AREA ANALYSIS
                    7.3.4.1 Surface area analysis helps determine performance characteristics of products
           7.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES
    7.4 METHOD DEVELOPMENT & VALIDATION SERVICES
           7.4.1 EXTRACTABLE & LEACHABLE METHOD DEVELOPMENT & VALIDATION
                    7.4.1.1 Extractable studies are required to facilitate the analysis of leachables and control leachables in final drug products
           7.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION
                    7.4.2.1 Presence of drug-substance and drug-product impurities to further support market growth
           7.4.3 STABILITY-INDICATING METHOD VALIDATION
                    7.4.3.1 Stability testing is regarded as being essential in understanding drug quality changes over time
           7.4.4 CLEANING VALIDATION
                    7.4.4.1 Cleaning validation processes are necessary to evaluate cleaning practices and ensure complete decontamination
           7.4.5 ANALYTICAL STANDARD CHARACTERIZATION
                    7.4.5.1 Analytical standard characterization plays a vital role in drug development
           7.4.6 TECHNICAL CONSULTING
                    7.4.6.1 Technical consulting services assist pharmaceutical and biopharmaceutical companies in meeting regulatory requirements
           7.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
    7.5 RAW MATERIAL TESTING SERVICES
           7.5.1 COMPLETE COMPENDIAL TESTING
                    7.5.1.1 Complete compendial testing detects the efficacy and safety of therapeutic products
           7.5.2 HEAVY METAL TESTING
                    7.5.2.1 Heavy metals in finished pharmaceutical products and raw materials are tested to ensure the quality of the product & patient safety
           7.5.3 CONTAINER TESTING
                    7.5.3.1 Container closure integrity testing helps optimize sealing, evaluate temperature impact, and replace sterility tests for product stability batches
           7.5.4 KARL FISCHER ANALYSIS
                    7.5.4.1 Need to check for water content in pharmaceutical products to support the market growth
           7.5.5 WET CHEMISTRY ANALYSIS
                    7.5.5.1 Wet chemistry analysis provides qualitative and quantitative data on elements in samples
           7.5.6 OTHER RAW MATERIAL TESTING SERVICES
    7.6 BATCH-RELEASE TESTING SERVICES
           7.6.1 DISSOLUTION TESTING
                    7.6.1.1 Dissolution testing plays a vital role in the pharmaceutical industry, from R&D to the control and evaluation of drug quality
           7.6.2 ELEMENTAL IMPURITY TESTING
                    7.6.2.1 The need to detect organic and inorganic impurities in active pharmaceuticals and ingredients drives demand for elemental impurity testing
           7.6.3 DISINTEGRATION TESTING
                    7.6.3.1 Disintegration testing is performed to ensure batch-to-batch consistency of pharmaceutical dosage forms
           7.6.4 HARDNESS TESTING
                    7.6.4.1 Hardness testing helps determine resistance to mechanical shocks and tablet strength
           7.6.5 FRIABILITY TESTING
                    7.6.5.1 Friability testing measures the resistance of tablets and granules to abrasion or fracture
           7.6.6 OTHER BATCH-RELEASE TESTING SERVICES
    7.7 STABILITY TESTING SERVICES
           7.7.1 DRUG SUBSTANCE STABILITY TESTING
                    7.7.1.1 Substance stability testing is a necessary step in the drug approval process
           7.7.2 FORMULATION EVALUATION STABILITY TESTING
                    7.7.2.1 These tests provide data on expiry and storage conditions required
           7.7.3 ACCELERATED STABILITY TESTING
                    7.7.3.1 Accelerated stability testing determines the shelf-life of a pharmaceutical product by measuring degradation caused by stress
           7.7.4 PHOTOSTABILITY TESTING
                    7.7.4.1 Photostability tests establish the effect of light exposure on products
           7.7.5 COMPARATIVE STABILITY TESTING
                    7.7.5.1 Comparator studies and blind comparator stability testing are performed to check if a pharmaceutical product is equivalent or superior to the marketed drug product in the same therapeutic class
           7.7.6 OTHER STABILITY TESTING SERVICES
    7.8 MICROBIAL TESTING SERVICES
           7.8.1 MICROBIAL LIMIT TESTING
                    7.8.1.1 Microbial limit testing determines whether a product complies with compendial specifications for microbial quality
           7.8.2 STERILITY TESTING
                    7.8.2.1 Sterility testing of a pharmaceutical product is required during the sterilization validation process and routine release testing to enhance product quality
           7.8.3 ENDOTOXIN TESTING
                    7.8.3.1 LAL tests are used to test for the presence of endotoxins, in compliance with regulatory requirements
           7.8.4 PRESERVATIVE EFFICACY TESTING
                    7.8.4.1 Preservative efficacy testing determines the type and minimum effective concentration of preservatives required for a formulation
           7.8.5 WATER TESTING
                    7.8.5.1 Need to ensure water quality creates demand for water testing
           7.8.6 OTHER MICROBIAL TESTING SERVICES
    7.9 ENVIRONMENTAL MONITORING SERVICES
           7.9.1 AIR TESTING
                    7.9.1.1 Air contamination can prove highly harmful to product quality, which necessitates regular testing
           7.9.2 WASTEWATER/ETP TESTING
                    7.9.2.1 Need to minimize water contamination supports the demand for wastewater testing
           7.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES

8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER (Page No. - 133)
    8.1 INTRODUCTION
    8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
           8.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE HEALTHCARE TESTING SERVICES MARKET
    8.3 MEDICAL DEVICE COMPANIES
           8.3.1 R&D SPENDING ON MEDICAL DEVICE DEVELOPMENT HAS INCREASED IN RECENT YEARS
    8.4 CONTRACT RESEARCH ORGANIZATIONS
           8.4.1 INCREASING FOCUS ON OUTSOURCING WILL SUPPORT MARKET GROWTH

9 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION (Page No. - 140)
    9.1 INTRODUCTION
    9.2 NORTH AMERICA
           9.2.1 US
                    9.2.1.1 The US dominated the North American healthcare analytical testing services market in 2019
           9.2.2 CANADA
                    9.2.2.1 Increasing number of clinical trials to support the growth of the market
    9.3 EUROPE
           9.3.1 GERMANY
                    9.3.1.1 Germany is the largest market for healthcare analytical testing services in Europe
           9.3.2 UK
                    9.3.2.1 Increasing partnerships between the government, the NHS, and the life sciences to support the market growth
           9.3.3 FRANCE
                    9.3.3.1 Growing number of biologics to drive the demand for analytical testing services
           9.3.4 ITALY
                    9.3.4.1 Growing number of clinical trials to support the market in Italy
           9.3.5 SWITZERLAND
                    9.3.5.1 Large and growing pharma production volume will drive demand for analytical testing services
           9.3.6 SPAIN
                    9.3.6.1 Rising R&D expenditure to boost the growth of analytical testing services
           9.3.7 REST OF EUROPE
    9.4 ASIA PACIFIC
           9.4.1 CHINA
                    9.4.1.1 Large pharmaceutical R&D footprint in China will drive market growth
           9.4.2 JAPAN
                    9.4.2.1 Japan is notable for demonstrating strong support for R&D
           9.4.3 INDIA
                    9.4.3.1 India to offer lucrative growth opportunities for market players
           9.4.4 AUSTRALIA
                    9.4.4.1 Australia is a favorable location for drug discovery due to the large number of research institutes in the country
           9.4.5 SOUTH KOREA
                    9.4.5.1 Growth in clinical trial activity to support the market in South Korea
           9.4.6 REST OF ASIA PACIFIC
    9.5 LATIN AMERICA
           9.5.1 GROWING R&D EXPENDITURE TO DRIVE MARKET GROWTH
    9.6 MIDDLE EAST & AFRICA
           9.6.1 MIDDLE EASTERN COUNTRIES ARE BECOMING ATTRACTIVE DESTINATIONS FOR PHARMA & MEDICAL DEVICE MANUFACTURERS

10 COMPETITIVE LANDSCAPE (Page No. - 254)
     10.1 OVERVIEW
     10.2 GROWTH STRATEGY MATRIX (2017–2020)
     10.3 MARKET SHARE ANALYSIS
             10.3.1 MARKET SHARE ANALYSIS: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
     10.4 COMPETITIVE LEADERSHIP MAPPING
             10.4.1 VISIONARY LEADERS
             10.4.2 INNOVATORS
             10.4.3 DYNAMIC DIFFERENTIATORS
             10.4.4 EMERGING COMPANIES
     10.5 COMPETITIVE SITUATION AND TRENDS
             10.5.1 SERVICE LAUNCHES AND UPGRADES
             10.5.2 ACQUISITIONS
             10.5.3 PARTNERSHIPS AND COLLABORATIONS
             10.5.4 EXPANSIONS

11 COMPANY PROFILES (Page No. - 262)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)* 
     11.1 EUROFINS SCIENTIFIC
     11.2 LABCORP
     11.3 SGS
     11.4 CHARLES RIVER LABORATORIES
     11.5 WUXI PHARMATECH
     11.6 PPD
     11.7 ELEMENT MATERIALS TECHNOLOGY
     11.8 PACE ANALYTICAL
     11.9 INTERTEK
     11.1 0MERCK KGAA
     11.11 SOURCE BIOSCIENCE
     11.12 ALMAC GROUP
     11.13 ICON
     11.14 FRONTAGE LABS
     11.15 STERIS PLC
     11.16 PRA HEALTH SCIENCES
     11.17 SYNEOS HEALTH
     11.18 MEDPACE
     11.19 LGC LIMITED
     11.20 ANACURA
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 315)
     12.1 INSIGHTS OF INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 AVAILABLE CUSTOMIZATIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS


LIST OF TABLES (291 Tables)

TABLE 1 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
TABLE 2 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS
TABLE 3 DEVELOPMENT OF GLP ACROSS COUNTRIES
TABLE 4 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
TABLE 5 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
TABLE 6 DRUGS UNDER TRIAL FOR THE TREATMENT OF COVID-19
TABLE 7 VACCINES CURRENTLY UNDER TRIAL FOR THE TREATMENT OF COVID-19
TABLE 8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 CELL-BASED ASSAY SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 VIROLOGY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 BIOMARKER TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 PHARMACOKINETIC TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 18 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 THERMAL ANALYSIS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 IMAGE ANALYSIS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 SURFACE AREA ANALYSIS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 EXTRACTABLE & LEACHABLE METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 CLEANING VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 TECHNICAL CONSULTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 34 RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 HEAVY METAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 CONTAINER TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 KARL FISCHER ANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 WET CHEMISTRY ANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 42 BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING
TABLE 44 DISSOLUTION TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 BREAKDOWN OF DISINTEGRATION METHODS AND IMMERSION MEDIA
TABLE 47 DISINTEGRATION TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 HARDNESS TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 FRIABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 ACCELERATED STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 PHOTOSTABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 COMPARATIVE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 OTHER STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 61 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING
TABLE 62 MICROBIAL LIMIT TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 STANDARDIZED LIMITS FOR WATER TESTING
TABLE 67 WATER TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 OTHER MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR
TABLE 72 AIR TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 STANDARDS FOR WASTEWATER QUALITY
TABLE 74 WASTEWATER/ETP TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 R&D SPENDING OF LEADING MEDICAL DEVICES COMPANIES, 2018 (USD BILLION)
TABLE 79 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR CROS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 81 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 103 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
TABLE 104 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 114 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 115 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 125 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 135 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 145 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 149 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 150 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 155 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY (2017)
TABLE 156 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 157 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 158 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 166 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 167 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 176 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 184 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 186 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 ROE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 ROE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 ROE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 ROE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 192 ROE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 193 ROE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 ROE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 196 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 197 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 APAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 APAC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 200 APAC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 201 APAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 202 APAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 APAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 APAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 APAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 207 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 208 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 209 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 210 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 214 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 215 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 216 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 217 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 220 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 221 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 222 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 226 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 227 INCREASE IN R&D EXPENDITURE OF TOP FIVE INDIAN PHARMACEUTICAL COMPANIES, 2010 VS. 2018 (USD MILLION)
TABLE 228 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 232 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 234 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 235 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 236 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 237 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 238 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 239 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 240 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 241 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 242 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 243 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 244 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 245 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 246 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 247 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 248 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 249 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 250 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 251 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 252 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 253 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 254 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 256 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 257 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 258 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 259 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 260 ROAPAC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 261 ROAPAC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 ROAPAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 263 ROAPAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 264 ROAPAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 265 ROAPAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 266 ROAPAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 267 ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 268 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 269 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 270 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 271 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 272 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 273 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 274 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 275 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE,2018–2025 (USD MILLION)
TABLE 276 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 277 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 279 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 280 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 281 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 282 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 283 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 284 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 285 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 286 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 288 SERVICE LAUNCHES AND UPGRADES, 2017–2020
TABLE 289 ACQUISITIONS, 2017–2020
TABLE 290 PARTNERSHIPS, 2017–2020
TABLE 291 EXPANSIONS, 2017–2020


LIST OF FIGURES (40 Figures)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025
FIGURE 9 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 11 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IS PROJECTED TO WITNESS DOUBLE-DIGIT GROWTH RATE
FIGURE 12 CHINA TO REGISTER THE HIGHEST GROWTH IN THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 13 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2019–2025)
FIGURE 14 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
FIGURE 15 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2002–2020)
FIGURE 17 EMPHASIS ON INORGANIC GROWTH AND PREFERENCE FOR LONG-TERM COLLABORATIONS OVER SHORT-TERM CONTRACTS ARE KEY MARKET TRENDS
FIGURE 18 MARKET DEVELOPMENTS, BY TYPE, 2017–2020: ACQUISITIONS FORM THE MOST-ADOPTED STRATEGY
FIGURE 19 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE MARKET IN 2025
FIGURE 20 R&D SPENDING OF PHRMA MEMBER-COMPANIES, 1995–2018
FIGURE 21 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 22 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
FIGURE 23 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 24 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019)
FIGURE 25 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 26 SPAIN: PHARMACEUTICAL R&D EXPENDITURE, 2011–2017
FIGURE 27 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 28 ACQUISITIONS—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
FIGURE 29 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 30 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019)
FIGURE 31 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 32 LABCORP: COMPANY SNAPSHOT (2019)
FIGURE 33 SGS: COMPANY SNAPSHOT (2019)
FIGURE 34 CHARLES RIVER LABORATORY: COMPANY SNAPSHOT (2019)
FIGURE 35 WUXI PHARMATECH: COMPANY SNAPSHOT (2019)
FIGURE 36 INTERTEK: COMPANY SNAPSHOT (2019)
FIGURE 37 MERCK: COMPANY SNAPSHOT (2019)
FIGURE 38 ICON PLC: COMPANY SNAPSHOT (2019)
FIGURE 39 FRONTAGE LABS: COMPANY SNAPSHOT (2018)
FIGURE 40 STERIS PLC: COMPANY SNAPSHOT (2019)

This study involved the extensive use of both primary and secondary sources. The research process included a study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the healthcare analytical testing services market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, presidents, vice presidents, marketing managers, product managers, sales executives, business development executives, and technology & innovation directors of companies providing healthcare analytical testing services as well as key opinion leaders in pharmaceutical companies, medical device companies, and CROs. A breakdown of primary respondents is provided below:

Healthcare Analytical Testing Services Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends by type and end user).

Data Triangulation

After arriving at the market size, the total healthcare analytical testing services market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study:

  • To define, describe, and forecast the global healthcare analytical testing services market by type, end user, and region.
  • To provide detailed information about the key factors influencing market growth (such as drivers, opportunities, restraints, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall healthcare analytical testing services market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the healthcare analytical testing services market in five main regions (along with major countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa
  • To profile key players in the global healthcare analytical testing services market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as mergers and acquisitions; service launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global healthcare analytical testing services market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • Further breakdown of the RoAPAC market into New Zealand, and other countries
  • Further breakdown of the RoE market into Russia, the Netherlands, and other countries
Report Code
AST 4341
Published ON
Apr, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Analytical Testing Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home